The small Ras-related GTPase, TC10, has been classi®ed on the basis of sequence homology to be a member of the Rho family. This family, which includes the Rho, Rac and CDC42 subfamilies, has been shown to regulate a variety of apparently diverse cellular processes such as actin cytoskeletal organization, mitogen-activated protein kinase (MAPK) cascades, cell cycle progression and transformation. In order to begin a study of TC10 biological function, we expressed wild type and various mutant forms of this protein in mammalian cells and investigated both the intracellular localization of the expressed proteins and their abilities to stimulate known Rho family-associated processes. Wild type TC10 was located predominantly in the cell membrane (apparently in the same regions as actin ®laments), GTPase defective (75L) and GTP-binding defective (31N) mutants were located predominantly in cytoplasmic perinuclear regions, and a deletion mutant lacking the carboxyl terminal residues required for posttranslational prenylation was located predominantly in the nucleus. The GTPase defective (constitutively active) TC10 mutant: (1) stimulated the formation of long ®lopodia; (2) activated c-Jun amino terminal kinase (JNK); (3) activated serum response factor (SRF)-dependent transcription; (4) activated NF-kB-dependent transcription; and (5) synergized with an activated Rafkinase (Raf-CAAX) to transform NIH3T3 cells. In addition, wild type TC10 function is required for full HRas transforming potential. We demonstrate that an intact eector domain and carboxyl terminal prenylation signal are required for proper TC10 function and that TC10 signals to at least two separable downstream target pathways. In addition, TC10 interacted with the actin-binding and ®lament-forming protein, pro®lin, in both a two-hybrid cDNA library screen, and an in vitro binding assay. Taken together, these data support a classi®cation of TC10 as a member of the Rho family, and in particular, suggest that TC10 functions to regulate cellular signaling to the actin cytoskeleton and processes associated with cell growth.
Introduction
At least 13 proteins grouped into eight subfamilies make up the present Rho family of mammalian Rasrelated GTPases: Rho (three isoforms, RhoA, B and C), Rac (three isoforms, Rac1, 2 and 3), CDC42Hs/ G25K (two isoforms), RhoE/Rnd3 (three isoforms, RhoE/Rnd3, Rnd1/Rho6 and Rnd2/Rho7), RhoG, RhoD, RhoH/TTF and TC10 (each of the latter four subfamilies represented by a single isoform) (for review see Zohn et al., 1998) . Individual family members exhibit about 35% amino acid sequence identity with H-RAS, and are clearly Ras-related on the basis of their size (*200 amino acids), highly conserved amino acid sequences and the spacing of their guanine nucleotide binding domains. Rho subfamilies are more closely related to one another (450% identical) than to other Ras-related families and isoforms within a Rho subfamily are 490% identical. Like RAS, Rho family proteins are prenylated and methylated at their carboxyl termini and thus membrane associated for some period during their function.
Similar to other Ras-related proteins, Rho family members are inecient GTPases, binding both GTP and GDP tightly, and catalyzing the hydrolysis of GTP to GDP+P i slowly. The rates of GTP hydrolysis and guanine nucleotide release are accelerated greatly by GTPase Activating Proteins (GAPs) and Guanine nucleotide Exchange Factors (GEFs), respectively. Under normal cellular conditions (300 mM GTP, 10 mM GDP) increased GEF activity increases the Rho.GTP : Rho.GDP ratio, while increased GAP activity decreases it. This ratio is critical because Rho family proteins generally interact with their speci®c eectors when bound to GTP, but not to GDP (for review see Machesky and Hall, 1996; Tapon and Hall, 1997) . The GTPase, therefore functions primarily as a molecular switch. Speci®c GAP activity favors GTP hydrolysis and moves the switch into its inactive GDPcharged form; whereas speci®c GEF activity favors GTP binding and moves the switch into its active GTP-charged form which can bind eectors to generate and/or transmit signals.
Proteins in the mammalian CDC42, Rac, and Rho subfamilies are implicated in the regulation of many cellular processes (for review see Machesky and Hall, 1996; Zigmond, 1996; Tapon and Hall, 1997; Mackay and Hall, 1998; Zohn et al., 1998) . These include formation of ®lopodia (CDC42), lamellipodia (Rac), stress ®bers and focal adhesion complexes (Rho), formation of other adhesive-like complexes (CDC42 and Rac), stimulation of Mitogen-Activated Protein Kinase (MAPK) cascades (CDC42 and Rac), and activation of gene expression (CDC42, Rac, and Rho). In addition, Rho family members play essential roles in G1 progression, initiation of DNA synthesis, and Rasmediated transformation (CDC42, Rac and Rho) Westwick et al., 1997) . Rho, Rac and CDC42 also activate Cyclin D1 transcription, providing a direct link to cell cycle regulation (Westwick et al., 1997) . The existence of a functional link between Rho family GTPases and cell cycle control in vivo is supported by the observation that several Rho family speci®c GEFs are proto-oncogenes.
Rho family GTPases regulate actin cytoskeletal rearrangements in a variety of cell types (Hall, 1998) . For example, treatment of quiescent Swiss 3T3 ®broblasts in culture with bradykinin induces formation of ®lopodia; treatment with epidermal growth factor (EGF) induces lamellipodia and treatment with lysophosphatidic acid (LPA) induces formation of stress ®bers (for review see Chant and Stowers, 1995; Machesky and Hall, 1996; Zigmond, 1996; Mackay and Hall, 1998; Zohn et al., 1998) . The eects of these physiological stimuli can be mimicked by injecting quiescent cells with constitutively active (GTPasedefective) mutant forms of Rho family GTPases. Microinjection of activated CDC42, Rac1, or RhoA induces the formation of ®lopodia, lamellipodia, or stress ®bers, respectively, each within minutes of injection. Further, dominant negative mutant proteins (which cannot bind GTP, bind GDP relatively poorly, and sequester GEFs by forming stable complexes) can inhibit the normal eects of the physiological stimuli. Dominant negative CDC42 inhibits the formation of ®lopodia induced by bradykinin; dominant negative Rac inhibits the formation of lamellipodia induced by EGF; and dominant negative Rho or Clostridium botulinum C3 transferase, which selectively ADPribosylates and inactivates Rho, inhibits the formation of stress ®bers induced by LPA. The complexity of actin cytoskeletal structures suggests that multiple steps are needed to link a GTPase to formation of such structures, and several observations suggest possible links between a known GTPase and the above proocesses (for review see Tapon and Hall, 1997; Hall, 1998; Mackay and Hall, 1998) . However, most of the events that link Rho family GTPases to the actin cytoskeleton remain to be identi®ed or characterized.
As previously noted, other major processes regulated by the Rho family are MAPK cascades. Various cellular stimuli or stresses activate the JNK/SAPK (cJun N-terminal Kinase/Stress Activated Protein Kinase) MAP kinase pathway, and Rac and CDC42 have been shown to control activation of this kinase cascade (for review see Vojtek and Cooper, 1995 ; Cahill et al., 1996; Mackay and Hall, 1998; Wasylyk et al., 1998) . Speci®cally, JNK is activated in cells expressing constitutively active CDC42 or Rac. JNK activation, in turn, results in the phosphorylation and activation of the transcription factors c-Jun and Elk-1, which stimulate transcription from genes containing AP-1 and SRE elements, respectively (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997;  for review see Wasylyk et al., 1998) . Further supporting a role for CDC42 and Rac in JNK signaling, JNK and cJun are activated in cells over-expressing GEFs that act on Rac and CDC42 (Westwick et al., 1998; Whitehead et al., 1998; Zhou et al., 1998) .
Rho family proteins also stimulate transcription through pathways independent of the JNK cascade. The transcription factor SRF (Serum Response Factor) cooperates with ternary complex factors, such as Elk-1, to stimulate transcription from promoters containing Serum Response Elements (SRE) such as c-fos (for review see Johansen and Prywes, 1995; Wasylyk et al., 1998) . Activated RhoA has no eect on JNK activation, but has been shown to stimulate SREmediated transcription. In addition, CDC42 and Rac activate SRF, by a pathway independent of JNK (Westwick et al., 1997; Whitehead et al., 1998; Zohn et al., 1998) . Rho, Rac and CDC42 have been implicated in the activation of the transcription factor Nuclear Factor kappa B (NF-kB) (Perona et al., 1997) . NF-kB plays an important regulatory role in expression of genes whose products are involved in the in¯ammatory response and control of cell death. Several lines of evidence suggest that MAP kinases, such as JNK, may mediate activation of NF-kB (for review see SchulzeOstho et al., 1997) .
Regions of CDC42 and Rac1 required for these and other cellular events have been examined by introducing eector mutations into activated proteins (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997) . These mutagenesis studies have centered on the region spanning amino acids 26 ± 43 of CDC42 and Rac1. This region corresponds to the well-conserved eector domain of Ras GTPases. Studies of CDC42 and Rac1 proteins with point substitutions in this region indicate that a GTPase may interact with multiple eectors to exert its biological functions. Dierential mutant phenotypes provide compelling, albeit indirect, support for the hypothesis that individual Rho family members interact with multiple downstream targets via multiple independent eectors.
The identi®cation and detailed characterization of eectors has played, and will continue to play, a major role in studies of the step by step pathways leading from GTPase activation to initiation of cellular eects. Numerous proteins have been classi®ed as eectors of Rho family members, because they interact directly with GTP-charged Rho family protein(s) but apparently do not function as GAPs or GEFs (for review see Machesky and Hall, 1996; Tapon and Hall, 1997; Mackay and Hall, 1998; Zohn et al., 1998) . For example, both CDC42.GTP and Rac.GTP activate the p21-activated kinase (PAK) family of serine/threonine protein kinases by binding to an 18 amino acid motif of PAK called the CDC42/Rac-interactive binding (CRIB) motif. PAK function has been implicated in Rac signaling to MAPK cascades and the actin cytoskeleton, but whether PAK is an essential mediator of these events is still unclear. Rac and CDC42 also bind and/or regulate a variety of other CRIB and non-CRIB motif containing proteins, but the speci®c roles of putative eectors in Rho family function remain to be determined.
In support of the classi®cation of TC10 as a Rho family GTPase, it has been reported recently that activated TC10 interacts with a variety of putative Rho family eectors, stimulates JNK, and induces ®lopodial formation (Neudauer et al., 1998) . In this communication, we con®rm many of these ®ndings and expand the study of this Rho family GTPase to include other signaling pathways as well as cellular transformation. Speci®cally, we show that wild type TC10 is located predominantly in the plasma membrane, a property that appears to depend both on its post-translational prenylation, and on its ability to bind and hydrolyze GTP. GTPase defective (activated) TC10 not only stimulates the formation of ®lopodia and activation of JNK, it also activates SRF-and NFkB-dependent transcription and synergizes with an activated Raf-1 kinase to transform NIH3T3 cells. We also demonstrate that TC10 is required for full transforming potential of oncogenic H-Ras. In addition, the properties of two activated, eector, TC10 double mutants suggest that there are separable pathways for TC10 function, and that these speci®c pathways may be similar to those initiated by CDC42 and Rac. Finally, we have identi®ed pro®lin, an actin binding protein known to regulate actin ®lament assembly, as a putative TC10 eector or regulator.
Results

TC10 is a member of the Rho family of Ras-related GTPases
TC10 was one of ®ve previously unknown Ras-related genes, together with Ran (TC4), Rac1 (TC25), R-Ras2 (TC21) and Rab 11, that we have identi®ed in hybridization and PCR screens of human teratocarcinoma cDNAs (Drivas et al., 1990) . Two TC10 homologous transcripts, of about 3 and 5 Kb, were detected by Northern blot analyses of poly(A) + RNA isolated from HeLa (endocervical carcinoma), Jurkat (T-cell), 293 (embryonic kidney), and N-tera-2 (teratocarcinoma) human cell lines, and similar transcripts were observed in mouse Swiss 3T3 cells. However, the TC10 transcripts were detected at low levels compared to transcripts of Rac1, Ran and RRas2. When N-tera-2 cells were induced to dierentiate by retinoic acid treatment, both TC10 transcripts were reduced about tenfold in abundance, a far greater reduction than that observed for the other GTPases (Drivas et al., 1990) . Preliminary Northern blotting studies of TC10 gene expression in adult mouse tissues suggest that the gene is widely expressed but at low levels compared to Rac1, Ran, and R-Ras2 (data not shown).
As shown in Figure 1 , the predicted protein sequence of TC10 has features characteristic of the Rho family members CDC42 (65% identity), Rac1 (62% identity) and RhoA (51% identity), including a carboxyl terminal`CAAX (cys-aliphatic-aliphatic-any) box' amino acid motif, the cysteine of which is targeted for prenylation in RAS superfamily members. It should be noted that the actual initiating methionine of TC10 (position 1 or 9) has not been determined, although we chose position 1 in the design of our fusion constructs. In the cDNA, the codons for methionines 1 or 9 are both in good translation initiation contexts (not shown).
To study TC10 function, we designed and constructed mutations in the TC10 coding sequence analogous to classical Ras mutations that trap the GTPase in a GTP-or GDP-bound state or interfere with downstream interactions and/or functions. Shown in Figure 1 are the positions of four substitution mutants and one deletion mutant that are relevant to the experiments presented in this report. The TC10 75L mutation is analogous to Ras 61L, which renders Ras insensitive to Ras GAP and constitutively bound to GTP; the TC10 31N mutation is analogous to Ras 17N which cannot bind GTP, binds GDP poorly, and sequesters GEFs (a dominant negative mutant); the TC10 49A and 54C mutations are analogous to mutations in Ras positions 35 and 40, which interfere with eector interactions; and the TC10 Cdel mutation is analogous to similar deletions of Ras that remove the CAAX motif required for posttranslational prenylation and disrupt membrane targeting. Figure 1 Sequence comparison of TC10, CDC42, Rac1, RhoA, and H-RAS. Amino acids are represented by the single letter code; dashes indicate gaps introduced to maximize homology; dots indicate residues identical to TC10. Residues identical among the four Rho family GTPases are in lower-case bold type; those identical among the four Rho family proteins and H-RAS are in uppercase bold type. The box indicates the conserved eector domain. Asterisks indicate the TC10 amino acids residues changed to generate dominant negative (31N), eector (49A or 54C) and activated (75L) mutants. D indicates the residues deleted to generate the TC10-CAAX box mutant. The wavy overline marks the sequence used to generate a TC10-speci®c antipeptide antibody TC10 GTP hydrolysis rates and guanine nucleotide release rates are similar to those of other Rho family proteins
In order to con®rm that TC10 is indeed a GTPase, and to investigate the kinetic properties of a putative GTPase defective (activated) TC10 75L mutant (analogous to Ras 61L), intrinsic rates of GTP hydrolysis and guanine nucleotide release were measured using histidine-tagged fusion proteins. Results of representative experiments are shown in Figure 2 . The tagged proteins bound to Ni 2+ resin were charged with either [g 32 P]GTP for hydrolysis studies, or [a 32 P]GTP for nucleotide release studies, and the percentage of radioactivity remaining on the resin was measured as a function of time (Murphy et al., 1997) . From these and other data, we estimate a hydrolysis rate constant of *10 73 s 71 and a release rate constant of *10 74 s
71
. As expected, the putative GTPase defective mutant (TC10 75L) hydrolyzed GTP extremely slowly (510 75 s
), but showed a wild type release rate. These results suggest that the TC10 75L mutant is a GTPase defective mutant and will be bound predominantly to GTP in vivo.
Wild type TC10 expressed in mammalian cells localizes predominantly in the plasma membrane.
In order to begin an analysis of TC10 biological function, we expressed T7 epitope-tagged wild type, dominant negative (31N), GTPase defective (75L), eector mutant (54C) and carboxyl terminal deleted (Cdel) TC10 proteins in mammalian cells and examined their intracellular distribution by immunostaining for the T7-epitope tag. The wild type protein localizes predominantly to the plasma membrane while the three substitution mutants distribute in the cytoplasm in perinuclear patterns, that are characteristic and reproducible for the three cell types tested (COS, HeLa, and BHK) ( Figures 3 and 4 and data not shown). Carboxyl terminal deletions of TC10 (Cdel and 75/Cdel) are found predominantly in the nucleus and diusely in the cytosol ( Figure 5 and data not shown). In addition, staining of wild type TC10-transfected COS cells with anti-T7 antibody plus rhodamine-phalloidin (speci®c for actin ®laments) results in a pattern that strongly suggests the colocalization of wild type TC10 and ®lamentous actin (Figure 4) .
These results indicate that TC10 localization is a dynamic process, depending on GTP binding (presumably de®cient in the dominant negative protein) and hydrolysis (defective in the GTPase defective mutant), and that distribution of the wild type protein is altered by a putative eector mutation or deletion of the carboxyl terminus. In addition, the data raise the possibility that localization of wild type TC10 mediates or is mediated by an interaction with actin.
GTPase defective TC10 induces the formation of ®lopodia (actin-containing spikes) in monkey kidney ®broblasts (COS cells) To analyse the relationship between TC10 and actin cytoskeletal organization further, we expressed various forms of T7-tagged proteins in serum-starved COS cells, and examined the cells by rhodamine-phalloidin staining ( Figures 5 and 6 ). Figure 5 shows representative micrographs of cells transiently transfected with vectors expressing wild type TC10, GTPase defective TC10 (75L), GTPase defective plus carboxyl terminal deleted TC10 (75L/Cdel), or GTPase defective plus 54C eector mutant TC10 (75L/54C). A quantitative summary of the results obtained with these and three additional constructs, TC10 Cdel, TC10 75L/49A (another activated, eector double mutant), and Rac 12V (a GTPase defective Rac mutant) is shown in Figure 6 .
As indicated in Figures 5 and 6, very few (*5% or less) of the non-transfected or vector transfected cells contain ®lopodia, as do few of the activated Rac V12 transfectants (*10%). In contrast, cells transfected with wild type TC10 exhibit a signi®cant percentage of cells containing multiple short ®lopodia (37%) but P]GTP, incubated with 1 mM cold GDP, and monitored for the release of radioactivity, a measure of intrinsic nucleotide exchange, as a function of time. Considerable GTP hydrolysis occurs over the time course of these experiments, so the nucleotide release rate measured for wild type protein is an average for labeled GTP and labeled GDP release. The observation that the rates of labeled nucleotide release for the GTPase defective mutant and wild type TC10 are essentially the same indicates that GTP and GDP release rates are similar none containing long ®lopodia, while cells transfected with GTPase defective TC10 exhibit a signi®cant percentage of cells containing multiple, long ®lopodia (45%) but very few containing short ®lopodia (1.5%). In addition, deletion of the ®ve carboxyl terminal amino acid residues from the wild type protein (Cdel) reduces the percentage of transfected cells containing short ®lopodia from 37 to 10%, while the same deletion in an activated TC10 (75L/Cdel) reduces the percentage of transfected cells containing long ®lopodia from 45% to zero. Interestingly, both of these deletion mutants localize predominantly to the nucleus (as shown for 75L/Cdel in Figure 5 ), suggesting that in the absence of proper post-translational modi®cation much TC10 is targeted by default to the nucleus. Not indicated in the ®gures is our observation that *60% of the Rac transfectants exhibited multiple large lamellipodia, compared to the essential absence of Figure 3 Cellular localization of TC10 and several TC10 mutants. HeLa and BHK cells grown on coverslips in DMEM plus 10% fetal calf serum were transfected with plasmids containing T7-epitope tagged constructs in serum free medium, and 6 h post transfection were maintained in 10% serum for 18 h. Cells were washed, ®xed, incubated with mouse anti-T7 antibody, and stained with anti-mouse antibody conjugated to¯uorescein. After washing, coverslips were mounted on glass slides and viewed with a Zeiss Axiophot¯uorescent microscope. The ®rst column of photomicrographs shows the localization of wild type TC10, the second the localization of an activated GTPase defective mutant (75L), the third a dominant negative mutant (31N), and the last an eector domain mutant (54C) Figure 4 Colocalization of TC10 and actin ®laments. COS cells on coverslips were transfected with a T7-epitope tagged wild type TC10 construct as described in the legend to Figure 3 , ®xed, permeabilized, incubated with mouse anti-T7 antibody and rhodamine phalloidin, and stained with¯uorescein-anti-mouse antibody. The left photomicrograph shows the localization of T7-TC10 (green), and the right shows the localization of actin ®laments (red). Non-transfected cells show essentially no staining with anti-T7 antibody in the presence of rhodamine-phalloidin such structures in any TC10 construct-transfected or non-transfected cells.
As noted previously, double mutants of Rac and CDC42 that are both activated and defective in selective eector function (analogous to the 75L/49A and 75L/54C double mutants of TC10 studies here) have been instrumental in identifying multiple independent eector pathways for each of these GTPases (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997) . As shown in Figure 6 , introduction of the 49A eector mutation (analogous to Rac and CDC42 position 35 eector mutants) into activated TC10 reduces the percentage of transfected cells containing multiple long ®lopodia from 45% to zero, while introduction of the 54C eector mutation (analogous to Rac and CDC42 40C) reduces this percentage by only about one half. Thus considering the multiple long ®lopodia phenotype to be indicative of activated TC10 function related to actin cytoskeleton reorganization, our results are consistent with the previously reported Rac and CDC42 data.
Taken together, the data presented in this section indicate that expression of wild type TC10 induces the formation of multiple short ®lopodia in serum starved COS cells, while expression of activated TC10 (75L) induces the formation of multiple long ®lopodia. In addition, mutation of TC10 75L at position 49 to alanine or removal of the carboxyl-terminal prenylation signal greatly interferes with the formation of long ®lopodia, whereas alteration at position 54 has less of an eect on the long ®lopodia phenotype. Figure 5 Reorganization of the actin cytoskeleton by TC10. Actively growing COS cells on coverslips were transfected with plasmids containing the T7-epitope tagged constructs indicated on the left. Cells were maintained in serum-free medium for 48 h to reduce the induction of actin-cytoskeletal structures by serum, then ®xed, permeabilized, incubated with mouse anti-T7 antibody and rhodamine-phalloidin, and stained with¯uorescein-anti-mouse antibody. The ®rst column of photomicrographs shows the anti-T7 stain, and the second the phalloidin stain. Photographs are overexposed to emphasize surface structure. Non-transfected cells generally show few or no actin-containing cell surface structures (not shown). See Figure 6 for quantitation of data from multiple transfections GTPase defective TC10 stimulates JNK, SRF and NF-kB activation Activated CDC42 and Rac mutants have been shown to stimulate JNK, SRF and NF-kB activation in transient transfection assays (Joneson et al., 1996; Lamarche et al., 1996; Perona et al., 1997; Westwick et al., 1997, for review see Machesky and . These stimulations are presumed to require an intact eector domain, since mutation at either position 35 or 40 abolishes CDC42-or Rac-mediated activation of JNK and SRF.
Since TC10 has the ability to induce ®lopodia formation, similar to CDC42, we sought to determine if TC10 biological function re¯ects other properties of CDC42 or Rac. We examined the ability of wild type, activated (75L), and the activated/eector domain double mutants, 75L/49A and 75L/54C (analogous to CDC42 and Rac, 35 and 40 eector mutants), to activate JNK, SRF, or NF-kB. As shown in Figures 7 ± 9, the results obtained for TC10 are essentially identical to those obtained previously for CDC42 and Rac (Joneson et al., 1996 , Lamarche et al., 1996 , Perona et al., 1997 , Westwick et al., 1997 . Speci®cally, TC10 75L stimulates JNK, SRF and NF-kB activity, while the eector mutants do not. The level of stimulation of JNK and NF-kB activities by TC10 75L is comparable to that observed with Rac 12V and CDC42 61L, while activation of SRF by TC10 75L is on average sevenfold less than that observed with Rac 12V, Rac 61L, or CDC42 61L (Figures 7 ± 9 and data not shown).
Also shown in Figures 7 ± 9 are the results of studies using a TC10 75L/Cdel double mutant. It should be recalled that TC10 75L/Cdel localizes predominantly to the nucleus ( Figure 5 ) and, in contrast to the single 75L mutant, loses the ability to induce multiple long ®lopodia ( Figure 6 ). Not surprisingly, TC10 75L/Cdel is also impaired in its ability to activate JNK, SRF and NF-kB, although the loss of activation is reproducibly less than that observed for the 49A and 54C eector mutants. Finally, it should be noted that, in agreement with studies of other small GTPases by other laboratories, overexpression of wild type TC10 did not in itself activate JNK, SRF or NF-kB under our assay conditions. GTPase defective TC10 synergizes with an activated Raf-1 kinase to transform NIH3T3 cells Activated (GTPase defective) forms of Rac1, RhoA, or CDC42 show little or no focus-forming activity when assayed in NIH3T3 ®broblasts. However, activated versions of all three proteins cooperate with activated forms of the Raf-1 serine/threonine protein kinase and exhibit synergistic focus forming activity in rodent ®broblast transfection assays (Westwick et al., 1997; Whitehead et al., 1998) . Therefore, we wanted to determine if activated TC10 also possesses transforming potential. As shown in Figure 10a , expression of either an activated Raf-1 protein that is targeted to the plasma membrane (Raf-CAAX) or TC10 75L alone resulted in transformation frequencies close to background levels. However, coexpression of activated TC10 75L with Raf-CAAX caused a tenfold (above additive) synergistic enhancement of focusforming activity. The foci formed were`Rho-like', rather than`Ras-like', showing growth and morphol- Figure 6 Quantitation of the reorganization of the actin cytoskeleton by TC10. COS cells transfected as described in the legend to Figure 5 were ®xed and stained with anti-T7 antibody and rhodamine-phalloidin. For each construct, a total of *300 cells from two separate experiments were analysed for short or long ®lopodia. Long ®lopodia are classi®ed as about ®ve times longer than short ®lopodia. The numbers shown represent the average per cent of transfected (a) or non-transfected (b) cells with a particular phenotype. Vertical lines in the bar graphs indicate the range of the two experiments. Non-transfected and vector transfected cells generally show few or no actin-containing cell surface structures (®lopodia or lamellipodia). In this study, the Rac 12V mutant induced the formation of many large lamellipodia in *60% of transfectants while such structures were rare (*1%) in the TC10 75L transfectants (data not shown) ogy similar to foci formed by activated Rho, Rac and CDC42 in cooperation assays with Raf-CAAX. Coexpression of TC10 activated/eector or activated/ Cdel mutants with Raf-CAAX did not lead to focus formation ( Figure 10a and Table 1 ). Cooperation in focus formation was also observed with activated TC10 75L and an activated Raf 340D mutant (data not shown).
Unlike activated forms of RhoA, Rac1 and CDC42, activated H-Ras 61L has high focus forming activity when expressed in NIH3T3 ®broblasts. In order to determine if TC10 is required for Ras-mediated focus formation, we coexpressed dominant negative TC10 31N with activated H-Ras 61L in NIH3T3 cells. Dominant negative TC10 31N causes a signi®cant, although incomplete reduction in Ras focus formation (*50%, Figure 10b ). Thus, wild type TC10 function is required for full transforming potential of oncogenic Ras.
TC10 binds pro®lin, a mediator of actin ®lament formation
The functional studies reported in the sections above strongly support the hypothesis that TC10, like other members of the Rho GTPase family, can interact with the actin cytoskeleton and with signaling cascades. To begin to analyse the molecular mechanisms of these interactions, we used the yeast two-hybrid assay to search for proteins with which TC10 might interact.
We cloned the full open reading frame of TC10 as a downstream fusion with the LexA DNA binding domain coding region of plasmid pEG202. This construct served as bait in a two-hybrid screen of a mouse B cell cDNA library in plasmid pJG4-5 (which expressed B42 transcription activation domain fusion proteins). A screen of 5610 6 yeast cells transformed with bait plus cDNA plasmids yielded a single positive. The interaction was maintained when the cloned fusion plasmid was re-tested against TC10 and an unrelated bait. Sequencing of this clone showed it to encode the carboxyl terminal 70 residues of mouse pro®lin I (100% identity to the published amino acids and nucleotide sequences) (Widada et al., 1989) . To con®rm the TC10-pro®lin interaction in vitro, we used a solution binding assay based on the interaction of immobilized His-tagged TC10 with a GST-pro®lin fusion protein. We also included a binding study to a GST-PAK3 protein fragment (CRIB domain) to con®rm this reported TC10 interaction (Neudauer et al., 1998) . As shown in Figure 11a , TC10.GTP, but not TC10.GDP, interacts with PAK, and as shown in Figure 11b , TC10.GTP, and to a lesser extent TC10.GDP, interacts with pro®lin I (generated from a monocyte cDNA library by PCR). The latter result con®rms the yeast two-hybrid data and demonstrates that a basal level of TC10-pro®lin interaction can be detected in the absence of TC10 processing and any accessory factors. Preliminary studies indicate that pro®lin is not a TC10-speci®c GAP or GEF (data not shown).
Since the actin binding protein pro®lin is proposed to play a major role in the conversion of globular to ®lamentous actin, and thus in the formation of ®lopodia, its selection in a two-hybrid system using the ®lopodial-inducing protein TC10 as bait is promising and suggests that pro®lin may be a TC10 eector.
Discussion
The small GTPase TC10 was identi®ed nearly 10 years ago, and except for preliminary RNA expression experiments, had remained essentially uncharacterized until recently (Drivas et al., 1990 ; Neudauer et al., Figure 9 Activation of NF-kB-dependent transcription by TC10. Actively growing COS cells were cotransfected with plasmids expressing either wild type or mutated TC10, or Rac 12V, and a reporter plasmid containing NF-kB binding elements fused to a ®re¯y luciferase gene. Cells were maintained, harvested, lysed, and examined for luciferase expression as described in Materials and methods. The bars represent the average per cent activation relative to TC10 75L for four experiments, and vertical lines mark the limits. Vector alone and mock transfected cells produced a level of activation similar to wild type TC10. The level of GTPase expression was similar for all samples Figure 10 Transformation potential of TC10. (a) Cooperation with Raf-CAAX in a focus formation assay. NIH3T3 cells were cotransfected with the indicated constructs, and after 12 ± 14 days of growth the dishes were stained with 0.4% crystal violet and photographed. Bars represent the average number of foci/dish obtained in three independent experiments, and the vertical lines mark the limits. (b) Inhibition of Ras-transformation by dominant negative TC10. NIH3T3 cells were cotransfected with the indicated constructs and treated as described in (a). Bars represent the average number of foci/dish for two independent experiments 1998; Murphy et al., this manuscript). On the basis of amino acid sequence, TC10 is most closely related to the CDC42 and Rac members of the mammalian Rho family (Figure 1) . We have initiated a systematic study of its function by examining its role in biological processes associated with other members of the Rho family. The results of this study are summarized in Table 1 . TC10 localizes predominantly to the plasma membrane and exhibits several of the cellular functions characterized for CDC42, Rac, and Rho. Similar to the action of CDC42 on the actin cytoskeleton, activated TC10 induces the formation of ®lopodia, and like CDC42 and Rac, activated TC10 stimulates JNK. Both of these properties were also observed by Neudauer et al. (1998) . In common with CDC42, Rac, and Rho, activated TC10 stimulates SRF-and NF-kB-dependent transcription and cooperates with Raf-CAAX in a synergistic focus forming transformation assay. In addition, dominant negative TC10 blocks oncogenic Ras focus forming activity, suggesting that TC10 function is required for Ras-mediated transformation. Also in common with CDC42, Rac, and Rho, activated TC10 stimulates transcription from a Cyclin D1 promoter, providing a more direct link to regulation of the cell cycle (G Murphy, unpublished observations). In addition, we show that TC10 interacts with the actin-binding protein pro®lin. We conclude that TC10 is functionally related more closely to CDC42 and Rac than it is to Rho, consistent with observed sequence identities (Figure 1) , and suggest that TC10 may play a pivotal role in actin cytoskeleton rearrangement, activation of gene expression, and oncogenic transformation.
To study the function of a GTP binding and hydrolyzing protein, many of the studies reported here for TC10, and elsewhere for other Ras-related GTPases, rely on mutational analysis. In particular, we have constructed a TC10 75L point mutant that is predicted to be defective in its GTPase activity. Since the in vivo regulation of Ras-related GTPases is assumed to depend on GEF and GAP activities, the operational de®nition of a GTPase defective mutant is that it does not respond, or responds poorly, to GAPs. The signi®cant decrease in the intrinsic GTP hydrolysis rate reported here for the TC10 75L mutant and the Figure 11 Binding of PAK and Pro®lin to TC10.GTP. *1 mg of His*Tag-TC10 immobilized on Ni 2+ resin was charged with GTP or GDP. Excess nucleotide was removed and the protein was incubated with *3 mg of GST, GST-PAK (a), or GST-Pro®lin (b) for 2 h at 48C. The resin was collected by centrifugation and washed with excess binding buer. Bound proteins were separated by SDS ± PAGE, transferred to nitrocellulose, and probed with anti-GST antibody. Membranes were then incubated with ProteinG coupled to horseradish peroxidase, and GST antibody was visualized by chemiluminescence (Neudauer et al., 1998 ) that this mutant, but not wild type TC10, is resistant to a Rho family GAP (p50RhoGAP), suggest that this is a typical GTPase defective mutant that will be bound predominantly to GTP in vivo. It should also be noted that, in contrast to p50RhoGAP, no TC10 eective GEF has yet been reported (Hart et al., 1994; Zheng et al., 1995; Ren et al., 1998) .
Immunostaining of mammalian cells transiently expressing epitope-tagged TC10 proteins revealed that wild type TC10 localizes predominantly to the plasma membrane and Cdel TC10 predominantly to the nucleus, while the 75L, 31N, and 54C TC10 mutants distribute in perinuclear membrane-like patterns. The precise perinuclear localization (endoplasmic reticulum and/or Golgi) of the latter mutants is not clear from these studies, and will require colocalization experiments with known subcellular markers for clari®cation. The simplest explanation for the localization results where wild type TC10 is distributed predominantly in the plasma membrane while activated TC10 75L and dominant negative TC10 31N mutants are not, is that both binding and hydrolysis of GTP are required to maintain a large amount of TC10 in the membrane. At this time, it is not clear why such cycling of nucleotidebound GTPase may be required for plasma membrane localization. Perhaps this nucleotide turnover is necessary for assembly of a targeting complex, in analogy with the behavior of Ran and Rab proteins in intracellular transport processes. The observation that activated TC10 is indeed activating in function could re¯ect the fact that TC10.GTP can interact with eectors when free from the plasma membrane, or the fact that in overexpression, enough TC10.GTP is present at the plasma membrane to exert an eect. Moreover, the loss of function observed for TC10 75L/ Cdel could re¯ect the fact that the subcellular mislocalization of this mutant is incompatible with ecient TC10 function. Interestingly, although TC10 75L is not clearly detectable in the plasma membrane, it appears to be localized in intracellular membranes (Figure 3) , in sharp contrast to TC10 75L/Cdel which is predominantly nuclear and diuse in the cytosol. Since the dierence in distribution between the wild type and mutant proteins is so striking, we believe that the pattern observed with exogenous wild type TC10 re¯ects that of endogenous TC10, and is not a common artifact of exogenous expression of any TC10 construct. Studies performed to determine endogenous TC10 localization using a highly speci®c TC10 antipeptide (Figure 1) antibody, have been unsuccessful however, probably due to low TC10 expression levels (data not shown).
The data presented in Figures 5 and 6 indicate that expression of wild type TC10 induces the formation of multiple short ®lopodia, whereas expression of TC10 75L induces the formation of long ®lopodia. Moreover, a recent report (Neudauer et al., 1998) indicates that the ®lopodia induced by TC10 75L are signi®cantly longer than those induced by CDC42 61L, and that cells expressing TC10 75L produce nearly twice as many extensions as cells expressing CDC42 61L. In addition, detailed time-lapse images of cells expressing TC10 75L indicate that the actin structures formed are indeed ®lopodial extensions rather than retraction ®bers (Neudauer et al., 1998) .
We propose that the clear dierence in phenotype observed in cells expressing activated TC10 compared to wild type TC10 is due to sustained, strong TC10 75L signaling resulting in uncontrolled ®lopodial growth. This proposal is supported by the observation that the 75L/Cdel and 75L/49A double mutants fail to induce long ®lopodia, but can induce short ®lopodia (*13% of transfected cells) at a level above that observed for non-transfected, vector-transfected, or 75L-transfected cells (all less than 5%), but still well below the level observed for wild type TC10 (37%). In contrast, alteration of position 54 (75L/54C) resulted in about a 50% reduction in long ®lopodia suggesting that this position may be less involved in interactions with eectors that mediate cytoskeletal changes. Our results regarding TC10 regulation of the actin cytoskeleton are consistent with previously reported Rac and CDC42 data. This consistency is strengthened by the observation that neither TC10 75L/49A nor TC10 75L/54C activates JNK, SRF, or NF-kB (see below).
In addition to their eects on the cytoskeleton, Rho family proteins regulate gene expression and oncogenic transformation. We show here that like CDC42 and Rac, TC10 mediates activation of JNK, and like CDC42, Rac, and Rho, TC10 stimulates SRF-and NF-kB-dependent transcription, and synergizes with activated Raf-1 kinase to cause cellular transformation. Whether the eects of TC10 (and CDC42, Rac, and Rho) on gene expression are essential for cell transformation remains to be determined, since some Rac mutants that are severely defective in PAK, JNK, and SRF stimulation remain strongly transforming (Westwick et al., 1997) . It has been suggested that Rac transforming potential may be a result of activation of multiple pathways, some involving gene expression mechanisms such as activation of JNK and SRFdependent transcription and others not.
Coexpression of dominant negative TC10 with activated Ras caused a signi®cant reduction in Rasmediated focus formation. This approximately 50% reduction in focus forming activity is similar to that observed with dominant negative forms of RhoA, Rac1, and CDC42 (for review see Zohn et al., 1998) . The incomplete inhibition most likely re¯ects incomplete transfection eciencies and the fact that Ras probably uses multiple pathways to cause cellular transformation.
The fact that the strong phenotypes associated with TC10 are dependent on expression of the activated 75L mutant, indicates that overexpression of wild type TC10 alone is not sucient to induce a TC10-related eect. This view is supported by the observation that for every experiment reported here, the level of expression of each TC10 construct was equal to or slightly greater than that of the 75L mutant. A priori, it is possible that overexpression of wild type TC10 could also result in a strong phenotype. Although the ratio of TC10.GTP: TC10.GDP might not be altered, the absolute amount of TC10.GTP would increase in cells expressing exogenous wild type TC10. In fact, we believe that the weaker phenotype observed for wild type TC10 in the morphological assay, speci®cally the induction of multiple short ®lopodia (Figures 5 and 6) , is an example of the ability of overexpressed wild type protein to exert a clear biological eect. In this case, expression of TC10 75L appears to exaggerate the wild type phenotype by converting short ®lopodia to long ®lopodia ( Figure 6) . Therefore, at this time, ®lopodial induction may be the most sensitive of our TC10 functional assays. It should be considered that the phenotypes observed following expression of the TC10 75L mutant occur in a dominantly regulated cellular state, while the wild type TC10 is assumed to control these cellular processes in a more delicately regulated manner.
As noted previously, the study of activated/eector double mutants has been instrumental in elucidating multiple eector pathways for other Rho family members, particularly CDC42 and Rac (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997) . For example, 12V (activated)/35S (eector mutant) Rac is defective in all Rac induced phenotypes examined (including lamellipodia formation, transformation, JNK and SRF activation), while 61L (activated)/40C (eector) mutant Rac was defective in JNK and SRF activation but not in transformation or lamellipodia formation (Joneson et al., 1996; Lamarche et al., 1996; Westwick et al., 1997) . On the whole, our ®ndings are consistent with the CDC42 and Rac data in that the TC10 75L/49A mutant is defective in all phenotypes examined (®lopodial induction; JNK, SRF, NF-kB activation; and focus formation), while the TC10 75L/54C mutant is defective in all phenotypes examined except for ®lopodial induction. The latter ®nding is of particular interest, because it suggests that ®lopodial induction is mediated by a pathway that is distinct and separable from those mediating transcription factor activation and transformation. Thus, it is probable that TC10 exerts many of its biological eects via pathways similar to those used by CDC42 and Rac. This probability is consistent with the relatively highly conserved eector domains of the three proteins (Figure 1) , and the observation that in addition to PAK3 (Figure 11a ), TC10.GTP may bind directly to a variety of other putative CDC42 and Rac eectors, including PAK1, PAK2, Myotonic dystrophy kinaserelated CDC42 binding kinase a/b, mixed lineage kinase 2, and N-WASP (Neudauer et al., 1998) .
In addition to examining the properties of two activated/eector double mutants, we also examined an activated/carboxyl terminal deletion (75L/Cdel) double mutant. As with all members of the Rho family, the presence of a carboxyl terminal CAAX motif in TC10 indicates that the protein is processed by isoprenylation of the cysteine, followed by proteolytic removal of the three C-terminal amino acids and carboxymethylation. This processing suggests that TC10 associates with membranes for some period during its normal regulated function. Indeed, as shown in Figure 3 , exogenously expressed wild type TC10 is located predominantly in the plasma membrane, whereas TC10 Cdel and TC10 75L/Cdel proteins are located predominantly in the nucleus and diusely in the cytosol, but not in the plasma membrane ( Figure 5 and data not shown). As might have been expected from such a drastic alteration of normal cellular localization, the 75L/Cdel mutant is defective in all TC10 functions examined, but perhaps not as defective as the eector/ double mutants in activation of gene expression (Figures 7 ± 9 ). These properties of TC10 75L/Cdel may not be due solely to its unusual cellular localization however, since the 75L single mutant, which is active in all of the assays reported here, also exhibits an unusual cellular distribution (Figure 3 ).
The precise eectors of TC10, CDC42, and Rac, that is the proteins with which they interact directly to exert their eects on a de®ned process such as actin cytoskeletal rearrangements, gene activation and transformation, remain largely unknown, although a variety of putative eectors have been identi®ed. Therefore, identi®cation of a protein that binds directly to TC10, that does not appear to be a TC10 speci®c GAP or GEF, and that has been proposed previously to be a regulatory component of a pathway induced by TC10, is of particular interest. Such a protein is pro®lin (see Results). Pro®lin is a small protein (140 amino acids) that localizes in vivo with dynamic actin ®laments (Buû et al., 1992; Rothkegel et al., 1996) , binds and sequesters globular actin (G actin) in vitro, and functions to promote actin ®lament and microspike formation in vivo (for review of pro®lin function see Sohn and Goldschmidt-Clermont, 1994; Reinhard et al., 1995; Suetsugu et al., 1998) . The interaction of TC10 with pro®lin may provide valuable insights into mechanisms linking cytoskeletal rearrangements to the Rho family. For example, the recent observations that budding yeast Cdc42p and Rho1p, required for actin cytoskeletal reorganization during bud site initiation and growth, respectively, bind to Bni1p and that Bni1p is itself a pro®lin-binding protein that participates in cell polarization (Kohno et al., 1996; Evangelista et al., 1997) , suggest both that additional links may exist and that pro®lin may play a key role in all of them. We expect that a biochemical and functional characterization of the TC10 GTPase and its interactions with pro®lin may provide insight into general features of the links that couple Rho family GTPases to the cellular state of the actin cytoskeleton and to the processes that control cell cycle progression.
Irrespective of the actual pathways stimulated by TC10, are questions regarding the relationships of these stimulations to those observed for other members of the Rho family. Are TC10 functions independent of, or dependent upon, those of other GTPases known to stimulate the same overall processes? Speci®cally, is the ability of TC10 to stimulate ®lopodial formation, and activate gene expression via JNK, SRF, or NF-kB, independent of, or dependent upon, CDC42? Conversely, is the ability of CDC42 to stimulate these processes independent of, or dependent upon, TC10? Finally, even if TC10 and CDC42 function completely independently of one another, are they activated by the same or dierent signals, and do they follow the same or dierent pathways to exert their eects?
In essence, these questions address the concept of a GTPase cascade, in which activation of one GTPase leads to the subsequent activation of another (such as that identi®ed previously for the roles of CDC42, Rac and Rho in actin cytoskeletal organization, for review see Zigmond, 1996; Mackay and Hall, 1998) , versus the concepts of independent and even redundant pathways. The answer to these questions will require identi®cation of the extracellular signals that stimulate TC10, as well as the use of dominant negative GTPases to determine whether the function of one GTPase is dependent on the activation of another. At this time, the possibility of a cascade incorporating TC10, at least in regard to ®lopodial induction, seems likely since the ability of yet another family member, RhoG, to stimulate ®lopodial and lamellipodial formation requires CDC42 and Rac, respectively (Gauthier-Rouviere et al., 1998) . On the other hand, the inability of TC10 to induce lamellipodia or stress ®bers, both in our assay and in a similar assay with Swiss 3T3 cells (Neudauer et al., 1998) , suggests that Rac may not be downstream of TC10 in a cascade regulating cytoskeletal rearrangements. Whatever the pathways initiated or followed by TC10, the results presented in this report suggest that its regulatory roles will be as important as those proposed for the more extensively studied members of the Rho family.
Materials and methods
DNA constructs
Wild type TC10 cDNA in pMT2 (Drivas et al., 1990 ) was used as a PCR template to generate two TC10 open reading frame cassettes for subcloning into pET19b or pCGT (a generous gift of Dr Angus Wilson, New York University). In the case of pET19b, the cassette contained a 5' NdeI site and a 3' BamHI site to allow directional cloning downstream and in frame with the poly histidine tag of the vector (His*Tag, Novagen). In the case of pCGT, the cassette contained a 5' XbaI site and a 3' BamHI site to allow directional cloning downstream and in frame with the T7-epitope tag of the vector. Wild type TC10 subcloned into both the pET19b and pCGT vectors was then used to generate point mutants (75L, 31N, 75L/49A, 75L/54C, 49A and 54C) using the Stratagene PCR-based Quik-Change System according to the manufacturer's suggested conditions. Two TC10 carboxyl terminal deletion (Cdel and 75L/Cdel) PCR cassettes were generated from wild type or 75L TC10, respectively. The cassettes contained a 5' XbaI site and a 3'BamHI site, and coded for TC10 proteins lacking the ®ve carboxyl terminal amino acids (Figure 1 ). They were cloned downstream and in frame with the T7-epitope tag of pCGT.
Mammalian expression vectors for Rac 12V (pCGT) and Rac 61L (pCGN) were constructed as described previously (Westwick et al., 1997) .
A wild type TC10 PCR cassette containing a 5' EcoRI site and a 3' SalI site was cloned downstream and in frame with the LexA DNA binding domain of pEG202, for use as`bait' in a two-hybrid screen of a mouse B cell cDNA library. The cDNA library was cloned in the B42 transcriptional activation domain coding vector, pJG4-5, as reported previously (Ren et al., 1995) .
A full length cDNA cassette coding for pro®lin I (140 amino acids, Widada et al., 1989) was recovered by PCR from a monocyte cDNA library (a generous gift of Dr Dan Littman, New York University). The cassette contained a 5' EcoRI site and a 3' XhoI site, and was cloned downstream and in frame with the Glutathione S-Transferase (GST) tag of pGEX5 (Pharmacia).
The nature of all DNA constructs was con®rmed by sequencing.
GTP hydrolysis and nucleotide release (exchange) assays
Nucleotide exchange and hydrolysis assays were performed as described (Murphy et al., 1997) . Brie¯y, His*Tag-TC10 (wild type or 75L) was expressed from pET19b-TC10 and puri®ed from bacteria by anity to Ni 2+ resin. The immobilized TC10 was then charged with radioactive nucleotide, and incubated in the absence of presence of nonradioactive nucleotide for various amounts of time.
To examine nucleotide exchange, TC10 immobilized on the Ni 2+ support was incubated with 20 mCi of [a 32 P]GTP in 5 mM EDTA in PBS on ice for 15 min. TC10.GTP was then stabilized with 20 mM MgCl 2 . The TC10 resin was washed 56 in 20 mM Tris base pH 7.6, 100 mM NaCl, 15 mM MgCl 2 to remove excess labeled nucleotide. TC10 aliquots (*1 mM) were then incubated with 1 mM unlabeled nucleotide (GDP or GTP) at 308C for speci®c amounts of time up to 30 min. Reactions were terminated with cold buer and resin collected by centrifugation. The supernatant was saved as the`unbound label', while the pellet was washed, resuspended in buer and saved as the`bound label'. Samples were counted in a Beckman scintillation counter, and the amount of radioactive nucleotide released into the unbound fraction expressed as a per cent of the total for each time point.
GTP hydrolysis assays were carried out similarly except that [g 32 P]GTP was used, and the reactions incubated at 308C for up to 30 min without excess unlabeled nucleotide.
Reproducible results were obtained in four assays for both nucleotide exchange and GTP hydrolysis.
Cell culture and transfection conditions COS, HeLa, and BHK cells were grown at 378C, 10% CO 2 in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% fetal calf serum. Transient transfections (1 mg of each plasmid per 35 mm 2 dish) were carried out in serumfree medium by LipofectAMINE Reagent and a standard protocol as supplied by the manufacturer (Life Technologies). For immunostaining studies, cells were transferred to DMEM+10% serum 6 h post-transfection and grown for an additional 12 ± 18 h. For reporter assay or kinase assay studies, cells were treated as described above, but were then cultured in DMEM without serum for an additional 12 ± 24 h. For ®lopodia assays, cells were cultured without serum for 48 h immediately following transfection.
NIH3T3 cells were grown at 378C, 10% CO 2 in DMEM (high glucose) supplemented with 10% calf serum. Cells were cotransfected with 1 mg of pCGT-TC10 construct plus 20 ng Raf-CAAX construct by calcium phosphate coprecipitation as previously described (Clark et al., 1995) .
TC10 intracellular localization assays
COS, HeLa, or BHK cells actively growing on coverslips in DMEM plus 10% fetal calf serum were transfected with plasmids (pCGT) containing T7-epitope tagged TC10 constructs by LipofectAMINE Reagent in serum-free medium and 6 h post-transfection were maintained in 10% serum for 12 ± 18 h. After washing in PBS, cells were ®xed with 3% paraformaldehyde, permeabilized with 0.2% Triton X-100, incubated with mouse anti-T7 antibody for 30 min at room temperature, and stained with FITC-anti-mouse antibody for 30 min in the dark. After washing, coverslips were mounted with Mowiol and viewed with a Zeiss Axiophot¯uorescent microscope. For actin staining, COS cells were transfected and treated as above, but during the anti-T7 antibody staining the cells were also incubated with rhodamine-phalloidin for 30 min in the dark at room temperature. Three separate transfections for each cell line gave reproducible patterns of cell staining. It should be noted that non-transfected cells show essentially no staining with anti-T7 antibody in the absence or presence of rhodaminephalloidin.
TC10 ®lopodial induction assay
COS cells actively growing on coverslips were transfected with plasmids (pCGT) containing T7-epitope tagged TC10 or Rac constructs, in serum-free medium, and maintained in DMEM without serum for 48 h. Cells were then ®xed, stained with anti-T7 antibody and rhodamine-phalloidin, and viewed as described above. For each construct, a total of *300 cells from two separate experiments were analysed for short ®lopodia, long ®lopodia, or membrane rues. Long ®lopodia are classi®ed as about ®ve times longer than short ®lopodia. Non-transfected and vector transfected cells maintained in serum-free medium for 48 h generally show few or no actin-containing cell surface structures.
JNK activation assay
To examine JNK activation in vitro, COS cells were cotransfected in serum-free medium with a plasmid (pCGT) expressing either wild type or mutated TC10, or Rac 12V, and a plasmid expressing a GST-JNK2 fusion protein. Cells were transferred to DMEM+10% serum 6 h post transfection, grown for 18 h, and then transferred to serum-free medium for an additional 24 h. Cells were harvested and lysed in 100 ml of NP-40 lysis buer (10 mM Tris pH 8.0, 0.5% NP-40, 150 mM NaCl, 1.5 mM MgCl 2 1.5 mM DTT, 1 mM PMSF, 20 mM b-glycerophosphate) and centrifuged for 1 min at 1000 g to pellet cell debris. To precipitate the GST-JNK2 fusion protein, 40 ml of 50% glutathione-agarose (Sigma) was added, and the samples rocked at 48C for 30 min. The resin was then collected by low speed centrifugation for 1 min, washed three times with lysis buer, one time with 20 mM Tris pH 7.6, 0.5 M LiCl, 1 mM DTT, and one time in a kinase assay buer (10 mM HEPES pH 7.5, 5 mM MgCl 2 0.5 mM DTT, 10 mM b-glycerophosphate). One half of the washed resin was tested for kinase activity by addition of 0.1 mM ATP, 2 mCi [g 32 P]ATP and 5 mg GST-c-Jun (aa 1 ± 79) in kinase assay buer (35 ml total volume). Reactions were agitated at RT for 20 min, terminated by addition of SDS ± PAGE loading buer and resolved by polyacrylamide gel electrophoresis. Gels were stained, dried, and exposed to ®lm for various amounts of time (30 min ± 18 h). Autoradiographs were scanned, and band intensities were quantitated using NIH Image software. To examine the level of GST-JNK2 for each sample, the other half of the washed resin was subjected to immunoblotting using goat anti-GST polyclonal antibody (Promega) and RecProteinG coupled to horseradish peroxidase (Zymed). TC10 expression was monitored in cell extracts by immunoblotting with anti-T7 monoclonal antibody (Novagen) and anti-mouse IgG conjugated to horseradish perodixase (Amersham). Signal was detected by LumiGLO, an enhanced chemiluminescence detection kit (KPL). The level of TC10 expression was nearly identical for all samples analysed. The amount of precipitated GST-JNK2 varied slightly but not reproducibly among samples; however, this slight variation did not aect comparisons of JNK activities.
To examine endogenous JNK activation, COS cells were cotransfected in serum-free medium with a plasmid (pCGT) expressing either wild type or mutated TC10, or Rac 12V, a plasmid expressing a GAL4 DNA binding domain (aa 1 ± 147)-c-Jun (aa 1 ± 223) fusion protein, and a reporter plasmid containing ®ve GAL4 binding elements fused to ®re¯y luciferase gene (PathDetect Reporter System, Stratagene). Cells were transferred to DMEM+10% serum 6 h posttransfection, grown for 18 h, and then transferred to serumfree medium for an additional 24 h. Cells were harvested, lysed and examined for luciferase expression according to Luciferase Assay System standard protocol (Promega). The level of TC10 expression, monitored as described above, was nearly identical for all samples analysed.
SRF activation assay
COS cells were cotransfected in serum-free medium with a plasmid (pCGT) expressing either wild type or mutated TC10, or Rac 12V, and a reporter plasmid containing a serum response element (lacking the sequence for binding TCF) fused to a ®re¯y luciferase gene (Westwick et al., 1997) . Cells were maintained, harvested, lysed, and examined for luciferase expression, as described for JNK activation assays. The level of TC10 expression, monitored as described for JNK activation assays, was nearly identical for all samples analysed.
NF-kB activation assay
COS cells were cotransfected with a plasmid (pCGT) expressing either wild type or mutated TC10, or Rac 12V and a reporter plasmid containing three NF-kB binding elements fused to a ®re¯y luciferase gene (Galang et al., 1996) . Cells were maintained, harvested, lysed and examined for luciferase expression, as described for JNK assays. The level of TC10 expression, monitored as described for JNK activation assays, was analysed by immunoblotting and found to be nearly identical for all samples analysed.
Focus forming assay
NIH3T3 cells were cotransfected with 1 mg of a plasmid (pCGT) expressing wild type or mutant TC10 and 20 ng of a plasmid expressing Raf-CAAX or H-Ras 61L. After 12 ± 14 days of growth, the dishes were stained with 0.4% crystal violet, photographed, and analysed for foci formation as described previously (Clark et al., 1995; Westwick et al., 1997) .
Two hybrid cDNA library screen
In this system, the cDNA library was cloned in frame, downstream of the B42 activation domain (pJG4-5), and wild type TC10 was cloned in frame downstream of a LexA DNA binding domain. EGY48 yeast cells were then transfected with these constructs, selected for plasmid maintenance (His and Trp prototrophy), and screened for interaction under a double selection method (Leu prototrophy and b-galactosidase activity) as described previously (Ren et al., 1995) .
TC10 solution binding assay
His*Tag TC10, GST, GST-mPAK3-PBD (CRIB domain only, a generous gift of Dr Shubha Bagrodia, Cornell University), and GST-pro®lin, were isolated from transformed, induced bacterial cultures as described previously (Murphy et al., 1997) . In the case of His*Tag-TC10 (pET19b), the fusion protein was puri®ed on Ni 2+ resin (Novagen), while in the case of GST and GST fusion proteins (pGEX5), protein was puri®ed on glutathione-agarose (Sigma).
Solution binding assays were also performed as described previously (Murphy et al., 1997) . Brie¯y, *1 mg of His*Tag-TC10 immobilized on Ni 2+ resin was charged with GTP or GDP (as described above). Excess nucleotide was removed by washing and the protein was incubated with *3 mg of GST, GST-PAK, or GST-Pro®lin for 2 h at 48C. The resin was collected by centrifugation and washed with excess binding buer. Bound proteins were separated by SDS ± PAGE, transferred to nitrocellulose, and probed with anti-GST antibody. Membranes were then incubated with ProteinG coupled to horseradish peroxidase, and GST antibody was visualized by chemiluminescence (KPL).
Note added in proof Studies using GFP fusion constructs con®rm the plasma membrane localization of wild type TC10, con®rm the perinuclear localization of TC10 75L and TC10 54C, and extend the localization of TC10 75L and TC10 54C to include the plasma membrane.
